WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 3 fonti

For prostate cancer patients set on surgery, new hormone regimen may improve outcomes, study finds

By doing hormone therapy up front in prostate cancer cases, the hope was to shrink the relapse rate after surgery. Results were encouraging.

Raccontata dahealio.comstatnews.comindependent.co.uk

Confronto fonti

3 prospettive sulla stessa storia
AI · summaries
statnews.comStai leggendo2 g fa

For prostate cancer patients set on surgery, new hormone regimen may improve outcomes, study finds

By doing hormone therapy up front in prostate cancer cases, the hope was to shrink the relapse rate after surgery. Results were encouraging.

originale
healio.com2 g fa

‘Thrilling’: Regimen reduces metastasis, recurrence in high-risk prostate cancer

CHICAGO — The addition of apalutamide to androgen deprivation therapy before and after surgery improved outcomes among men with localized high-risk prostate cancer, according to findings presented in ASCO Annual…

Leggi questa versione → originale
independent.co.uk1 g fa

Prostate cancer breakthrough as drug combo gives patients a powerful new chance

Data from a late-stage trial, presented on Sunday, indicate that the treatment, administered six months before and after surgery, substantially increased the chances of eliminating cancer and reduced the risk of disease…

Leggi questa versione → originale

Timeline cronologica

  1. domenica 31 maggio 2026·healio.com

    ‘Thrilling’: Regimen reduces metastasis, recurrence in high-risk prostate cancer

    CHICAGO — The addition of apalutamide to androgen deprivation therapy before and after surgery improved outcomes among men with localized high-risk prostate cancer, according to…

  2. domenica 31 maggio 2026·statnews.com

    For prostate cancer patients set on surgery, new hormone regimen may improve outcomes, study finds

    By doing hormone therapy up front in prostate cancer cases, the hope was to shrink the relapse rate after surgery. Results were encouraging.

  3. lunedì 1 giugno 2026·independent.co.uk

    Prostate cancer breakthrough as drug combo gives patients a powerful new chance

    Data from a late-stage trial, presented on Sunday, indicate that the treatment, administered six months before and after surgery, substantially increased the chances of…